We're excited to welcome Seth Kelley and Priya Mathew to our coming interview franchise. nytco.com/press/seth-kel…

So proud 🤩💕

Thankful to Jenny Mueller MD and Christian Dagher for making this project come to life! ✨

SGO bound!!! San Diego, here we come! ☀️✈️🚀Aaron Praiss MD Sara Moufarrij Christian Dagher #SGOMtg2024

Grateful for this incredible team and their work to raise money and awareness for rare cancers Cycle for Survival! Aaron Praiss MD Bill Zammarrelli Ryan Kahn, MD, MHS Fionán Donohoe Tiffany Sia MD Sushmita Gordhandas

Teamwork makes the dream work! 💙💙💙

A recent study by Aaron Praiss MD and Team Ovary, Memorial Sloan Kettering Cancer Center found that short-term postoperative complications in patients undergoing intestinal surgery at the time of cytoreduction for ovarian cancer did not have an impact on oncologic outcomes. Oliver Zivanovic
pubmed.ncbi.nlm.nih.gov/37992548/

Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix International Society of Gynecologic Pathologists Aaron Praiss MD MSK Oncology Updates SGO IGCS ESGO ASCO OncoAlert sciencedirect.com/science/articl…

We are the luckiest to be mentored by the best!! 🌟🌟🌟

#Viewpoint : the use of opportunistic #salpingectomy , removal of the fallopian tubes for the primary prevention of #OvarianCancer in a woman already undergoing pelvic surgery for another indication.

ja.ma/42kf4Mf

Mentorship shout out to Róisín O’Cearbhaill 🌟🌟🌟

Fellows Forum @onclive welcoming our esteemed speaker, the one and only Dr Laurel Rice, and fellows from all over the country @sgo_org @gog_foundation

Helping to inspire, mentor, build, and sponsor the future of gyn oncology…

Enjoying a little pre-meeting beach jog with Aaron Praiss MD Tiffany Sia MD Teresa Boitano and Rebekah Summey. Loving this time to meet and get to know other fellows! Thanks OncLive.com

Taking a break🛀 from uterine cancers to highlight another one of our fellows' work! Aaron Praiss MD great presentation! MSK crushin💥 it today OncLive.com

Prepare the area 🖤💖

💜💜💜

Late breaking at #SGOMtg : In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than chemotherapy alone. nej.md/3FJ4J3R

Thanks to Dmitriy Zamarin MD PhD for incredible mentorship, so honored to present our project at #SGOMtg 🙌🏼🌟

⁦Aaron Praiss MD⁩ right up after ⁦Ryan Kahn, MD, MHS⁩! Feeling like a proud papa! ⁦MSKCC Team Uterus⁩ ⁦Team Ovary, Memorial Sloan Kettering Cancer Center⁩ #SGOmtg